Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Amortizatization of Intangibles: 2024-2025

Historic Amortizatization of Intangibles for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $1.9 million.

  • Kura Oncology's Amortizatization of Intangibles fell 44.02% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year change of. This contributed to the annual value of $13.1 million for FY2024, which is 39.50% up from last year.
  • Latest data reveals that Kura Oncology reported Amortizatization of Intangibles of $1.9 million as of Q3 2025, which was down 23.65% from $2.5 million recorded in Q2 2025.
  • Kura Oncology's 5-year Amortizatization of Intangibles high stood at $3.5 million for Q2 2024, and its period low was $1.9 million during Q3 2025.
  • Its 2-year average for Amortizatization of Intangibles is $2.9 million, with a median of $2.9 million in 2024.
  • Data for Kura Oncology's Amortizatization of Intangibles shows a maximum YoY tumbled of 44.02% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Kura Oncology's Amortizatization of Intangibles stood at $2.9 million in 2024, then crashed by 44.02% to $1.9 million in 2025.
  • Its Amortizatization of Intangibles was $1.9 million in Q3 2025, compared to $2.5 million in Q2 2025 and $2.7 million in Q1 2025.